Maria Eklind-Cervenka is Chief Medical Officer of Inceptua
Maria Eklind-Cervenka is the new Chief Medical Officer of Inceptua Group. Maria joins Inceptua from Sobi where she held the position of Head of Global...
Roald Dahl’s legacy supporting seriously ill children
Sophie Dziwinski, Head of Programmes at Roald Dahl’s Marvellous Children’s Charity, works hard to ensure seriously ill children have access to specialist nurses in...
PM Society Chair Craig Bradley promoted at Shire
Shire has appointed Craig Bradley as Product & Business Lead for Internal Medicine across the UK & Ireland. Bradley is now responsible for the...
Companies making a positive impact are more attractive to the UK workforce
New research by UK pharmaceutical company, MSD, has revealed that when it comes to work, money is not everything. In an online survey of...
How to find a graduate job in pharma
What does it take to land your first graduate job in the pharmaceutical industry? Megan Bryant has some useful advice. The pharmaceutical industry is continuously...
Certara appoint Dr Mark Holbrook as VP of QSTS division
Certara ®, a leader in model-informed drug development, regulatory science, market access and real-world evidence services, has announced that it has appointed Mark Holbrook,...
Tillotts appoint Dr. Boubekeur as Global Head of Innovation
Tillotts Pharma AG and the Zeria Group are pleased to announce and welcome Dr. Karima Boubekeur as the Group’s new Global Head of Innovation as per September 1st 2018. Karima will...
Sweet 16: Star celebrates an important milestone
This September, Star celebrate its 16th birthday and is looking back over an exciting and successful year so far. Turning 16 marks an important chapter...
Pierre Van Weperen joins Ashfield as MD for Commercial and Patient Solutions
Ashfield, part of UDG Healthcare, an international healthcare services provider, has announced the appointment of Pierre Van Weperen as Commercial and Patient Solutions UK...
The King’s Fund appoints Richard Murray as Chief Executive
Richard Murray, currently Director of Policy at The King’s Fund, has been appointed as its new Chief Executive. He will succeed Professor Sir Chris...
Latest articles
IMBRUVICA® misses primary endpoint in pancreatic cancer trial
AbbVie have released an update on the RESOLVE trial of IMBRUVICA® in combination with chemotherapy agents in metastatic pancreatic cancer. AbbVie, a research-based global biopharmaceutical company,...
Star Europe’s Amsterdam office off to positive start
Star Europe has reported good feedback in the Netherlands since opening its Amsterdam office in November. Supported by established resources and infrastructure, the team at...
EC approves Vertex’s ORKAMBI® for cystic fibrosis patients
Vertex Pharmaceuticals announces that the European Commission has granted approval of the label extension for ORKAMBI® for cystic fibrosis patients. The European Commission has granted approval...